Flagship Pioneering, LLC Long-Term Concentrated

CIK: 0001400240 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value ($000): $843,359 (100.0% shares, 0.0% debt)

Holdings (6)

MRNA Moderna Inc 65.2%

Value ($000) $550,068 Shares 4,632,149 Est. Cost $16.43 Unrealized +670.0%

SANA Sana Biotechnology Inc 16.2%

Value ($000) $136,510 Shares 25,001,856 Est. Cost $32.56 Unrealized -75.5%

FHTX Foghorn Therapeutics Inc 8.6%

Value ($000) $72,876 Shares 12,674,120 Est. Cost $19.16 Unrealized -68.9%

— Omega Therapeutics Inc 7.2%

Value ($000) $60,497 Shares 29,225,579 Est. Cost $17.39 Unrealized —

— Seres Therapeutics Inc 2.0%

Value ($000) $16,732 Shares 23,117,045 Est. Cost $7.75 Unrealized —

SYRS Syros Pharmaceuticals Inc 0.8%

Value ($000) $6,676 Shares 1,293,849 Est. Cost $7.03 Unrealized -25.3%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MRNA	Moderna Inc	4,632,149	$550,068	65.2%	$16.43	+670.0%	COM	60770K107
SANA	Sana Biotechnology Inc	25,001,856	$136,510	16.2%	$32.56	-75.5%	COM	799566104
FHTX	Foghorn Therapeutics Inc	12,674,120	$72,876	8.6%	$19.16	-68.9%	COM	344174107
—	Omega Therapeutics Inc	29,225,579	$60,497	7.2%	$17.39	—	COM	68217N105
—	Seres Therapeutics Inc	23,117,045	$16,732	2.0%	$7.75	—	COM	81750R102
SYRS	Syros Pharmaceuticals Inc	1,293,849	$6,676	0.8%	$7.03	-25.3%	COM	87184Q206